There are 2789 resources available
248P - The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE registry
Presenter: Marissa Meegdes
Session: ePoster Display
196P - Targeting ESR1 in breast cancer treatment: Repurposing of statins
Presenter: Eva Rahman Kabir
Session: ePoster Display
197P - Application of neo-bioscore staging to predict the benefit of pertuzumab in HER2 positive early breast cancer
Presenter: Laura Sánchez Escudero
Session: ePoster Display
200TiP - ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO
Presenter: Nadia Harbeck
Session: ePoster Display
201TiP - Evaluation of the feasibility of ultrasound-guided clipping of suspicious intramammary lesions in primary breast cancer patients receiving neoadjuvant therapy (Ultra3Detect)
Presenter: Efstathia Vlachou
Session: ePoster Display
156P - Impact of HER2 status (HER2-low versus HER2-0) on complete histologic response after neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC)
Presenter: Camille Domergue
Session: ePoster Display
157P - Moderate physical activity (MPA) modulates immune system in breast cancer (BC) patients during preoperative chemotherapy: The NEO-RUNNER study
Presenter: Ornella Garrone
Session: ePoster Display